INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 19, 2012 |
Director, EVP CSO Pres Regen Res Labs
Trans History: 628
|
Director, EVP CSO Pres Regen Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | -- | -- |
| Nov 30, 2012 |
SVP Res and Devel Sciences
Trans History: 660
|
SVP Res and Devel Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 17,182 | $181.01 | 41,939 |
| Nov 14, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | $11.64 | 67,532 |
| Nov 14, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | -- | -- |
| Dec 19, 2005 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
| Dec 19, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
| Dec 19, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
| Dec 19, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
| Mar 24, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 17,213 | $312.19 | 18,774,884 |
| Jul 10, 2018 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 17,221 | $365.56 | 456,396 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.